News and Stories

Professor Danton Char, Stanford University School of Medicine; Faculty Affiliate, Institute for Human-Centered Artificial Intelligence (HAI)

Accolades

Non-compete agreements typically restrict employees from joining competitors or starting similar businesses within a given timeframe and geographical area after leaving their jobs. These kinds of covenants have become enormously widespread in the American economy, and even more so in the sector of health care. 

We are excited to announce the new cohort of Johns Hopkins Masters students selected for the 2023-24 class of the Hopkins Business of Health Initiative’s Graduate Institute.  

Distinguished health economist and health policy researcher Melinda Buntin, PhD, has just been announced as Johns Hopkins’ newest Bloomberg Distinguished Professor. She holds primary appointments in the Department of Health Policy and Management in the Bloomberg School of Public Health and in the Carey Business School.

Rama Chellappa, Ph.D., Bloomberg Distinguished Professor, Johns Hopkins University, who discussed the university’s major investment in artificial intelligence and its implications for the future of medicine

Health Equity & Business: 9 Expert Takeaways The Hopkins Business of Health Initiative convened two experts in this work, Dr. Lisa Cooper and Ebony Thomas of the Bank of America Charitable Foundation, in a recent conversation to discuss best practices for health equity in business and where they see opportunities for growth. 

The Hopkins Business of Health Initiative (HBHI) had its Washington DC debut at a September 22 Open House at Johns Hopkins University’s (JHU) beautifully renovated 555 Pennsylvania Avenue building. The location was a testament to JHU’s commitment to engaging in debates of national and global policy. The event introduced HBHI and JHU to the community of national leaders working specifically on health policy in the nation’s capital, welcoming them to HBHI’s new “spiritual home.”

Professor Nicholson Price, J.D., Ph.D., Professor of Health, University of Michigan Law School

A public conversation around generative artificial intelligence (AI) in medicine is both long overdue and increasingly urgent. In health care applications, the stakes are heightened because of the intricate privacy considerations and the critical nature of decision-making. The potential positive impact is also enormous.